Application no. and date | 12163085.9 (espacenet) (Federated) (European Patent Register), 20070608 | Patent/reg. no. and date | DK/EP 2474521, 20160810 | Publication date | 20120711 | Priority no. and date | EP 06012565, 20060619 | EP pub. no. and date |
EP 2474521 20120711 | Effective date | | Applicant/owner | Newron Pharmaceuticals S.p.A., Via L. Ariosto, 21
20091 Bresso (MI), IT | Applicant ref. no. | 159975 | Inventor | Salvati, Patricia, Via Valera 16C
20020 Arese (MI), IT, Barbanti, Elena, Via dei Platani, 6
20093 Cologno Monzese (MI), IT, CACCIA, Carla, Via E. Fieramosca, 9
21013 Gallarate (VA), IT, Velardi, Francesco, Str. Priv. Mascagni, 21
28062 CAMERI (MO), IT, Ruffilli, Tiziano, Corso Avilianum, 87C
13856 VIGLIANO BIELLESE (BI), IT, Bogogna, Luigi, Via C. Battisti, 10C
28010 VAPRIO D'AGOGNA (NO), IT | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/165 (2006.01) , C07C 231/10 (2006.01) , C07C 231/12 (2006.01) , C07C 231/18 (2006.01) , C07C 233/13 (2006.01) | Title | Højrene 2-[4-(3- and 2-fluorbenzyloxy)benzylamino]propanamider til anvendelse som lægemidler og farmaceutiske formuleringer dermed | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|